|Last Price$101.51||Day Change (%)-0.74%|
|Open Price$102.31||Day Change ($)-0.76|
|Day Range100.93–102.70||52-Week Range77.87–103.99|
As of Mon 8/3/2015 5:52:00 PM | USD
Research and Markets: Europe Markets for Bone Graft Substitutes 2011-2021 Featuring Baxter, Biomet, Bonalive, Depuy Synthes, Fin-Ceramica, Medtronic, RTI Biologics, Stryker , Wright Medical & Zimmer
Research and Markets: Global Market Study on Orthopedic Trauma Devices 2014-2020: Thermo Fisher Scientific Is the Leading Player Followed by Stryker , Zimmer Holding, Smith & Nephew & Orthofix Holding
CORRECTING and REPLACING Kareo Secures over $55 Million in Investment to Extend Market Leadership
Stryker SYK reported first-quarter operating results Wednesday that were slightly better than we'd anticipated, but not enough to move the needle on our fair value estimate. Revenue grew 13% year over year, with a nearly 200-basis-point boost from foreign currency benefits. We continue to expect ...
Research and Markets: Iraq Healthcare (Surgical Procedures) Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022
Research and Markets: US Market for Orthopedic Soft Tissue and Sports Medicine 2011-2015 & 2015-2021
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Industry dynamics are shifting in the wake of Zimmer's Biomet acquisition.
Med-tech multinationals look to the East for growth in China.
Rising interest rates have taken their toll, but as the Fed delays dialing back on stimulus, investors are poised to recapture some of their losses.